Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Pietropaolo

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|June 8, 2013
Persistent C-peptide: what does it mean?Massimo Pietropaolo
Plos Medicine|May 27, 2005
An 18-year-old patient with type 1 diabetes undergoing surgeryMassimo Pietropaolo
Drugs of the Future|August 8, 2012
GAD65 autoantibodies and its role as biomarker of Type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA)Roberto Towns, Massimo Pietropaolo
Immunology and Cell Biology|April 24, 2013
Autoimmunity treatment using pMHC-NP-based therapy: designing nanoparticle treatment of autoimmunity with quantitative biologySantiago Schnell, Massimo Pietropaolo
The Journal of Clinical Investigation|January 3, 2020
Time to dissect the autoimmune etiology of cancer antibody immunotherapyMichael Dougan, Massimo Pietropaolo
Pediatric Diabetes|April 27, 2010
AIRE's partnerships: an answer for many questions and new questions in search of answersRoberto Towns, Massimo Pietropaolo
The Journal of Clinical Endocrinology and Metabolism|October 10, 2006
Editorial: Metabolism lessons for survival: when adults and children are not alikeElif Arioglu Oral, Massimo Pietropaolo
Diabetes|February 28, 2009
Autoimmune pancreatitis: the emerging role of serologic biomarkersJohn W Wiley, Massimo Pietropaolo
Pediatric Diabetes|December 2, 2010
Type 1 diabetes: a genetic Pandora's box?Inas H Thomas, Massimo Pietropaolo
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and preventionNick Giannoukakis, Massimo Pietropaolo, Massimo Trucco
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
Current Opinion in Endocrinology, Diabetes, and Obesity|June 8, 2013
Persistent C-peptide: what does it mean?Massimo Pietropaolo
Plos Medicine|May 27, 2005
An 18-year-old patient with type 1 diabetes undergoing surgeryMassimo Pietropaolo
Drugs of the Future|August 8, 2012
GAD65 autoantibodies and its role as biomarker of Type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA)Roberto Towns, Massimo Pietropaolo
Immunology and Cell Biology|April 24, 2013
Autoimmunity treatment using pMHC-NP-based therapy: designing nanoparticle treatment of autoimmunity with quantitative biologySantiago Schnell, Massimo Pietropaolo
The Journal of Clinical Investigation|January 3, 2020
Time to dissect the autoimmune etiology of cancer antibody immunotherapyMichael Dougan, Massimo Pietropaolo
Pediatric Diabetes|April 27, 2010
AIRE's partnerships: an answer for many questions and new questions in search of answersRoberto Towns, Massimo Pietropaolo
The Journal of Clinical Endocrinology and Metabolism|October 10, 2006
Editorial: Metabolism lessons for survival: when adults and children are not alikeElif Arioglu Oral, Massimo Pietropaolo
Diabetes|February 28, 2009
Autoimmune pancreatitis: the emerging role of serologic biomarkersJohn W Wiley, Massimo Pietropaolo
Pediatric Diabetes|December 2, 2010
Type 1 diabetes: a genetic Pandora's box?Inas H Thomas, Massimo Pietropaolo
Current Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and preventionNick Giannoukakis, Massimo Pietropaolo, Massimo Trucco
Pageof 8